CPAP doesn't alter renal function in coexisting OSA, CVD

August 11, 2017

(HealthDay)—For individuals with coexisting obstructive sleep apnea (OSA) and cardiovascular disease, continuous positive airway pressure (CPAP) does not alter renal function, according to a study published online July 25 in the American Journal of Respiratory and Critical Care Medicine.

Kelly A. Loffler, Ph.D., from Flinders University in Daw Park, Australia, and colleagues examined the effects of CPAP on renal function in individuals with coexisting OSA and in a substudy of the international Sleep Apnea and Cardiovascular Endpoints trial. Renal function and adverse events were compared between 102 CPAP treated and 98 usual-care treated patients.

The researchers found that after a median period of 4.4 years, the median change in estimated glomerular filtration rate did not differ significantly between the CPAP and usual-care groups. No between-group differences were seen in the end-of-study urinary albumin:creatinine ratio or the occurrence of serious renal or urinary adverse events. The findings were not influenced by the level of CPAP adherence.

"CPAP treatment of OSA in patients with cardiovascular disease does not alter , nor the occurrence of renal ," the authors write.

Respironics Sleep and Philips Respironics provided funding for the trial.

Explore further: SAVE - sleep apnea treatment: No cardiovascular benefit

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

SAVE - sleep apnea treatment: No cardiovascular benefit

August 29, 2016
More than 3 years of nightly treatment with a continuous positive airway pressure (CPAP) machine did not reduce cardiovascular risk more than usual care among patients with cardiovascular disease and obstructive sleep apnea ...

Sleep apnea treatment may reverse unhealthy brain changes

September 15, 2015
(HealthDay)—Sleep apnea treatment may reverse changes in brain stem activity associated with increased risk of heart disease, a new study suggests.

Basal metabolic rate down after CPAP initiation in OSA

November 10, 2016
(HealthDay)—For patients with obstructive sleep apnea (OSA), treatment with continuous positive airway pressure (CPAP) is associated with a decrease in basal metabolic rate (BMR), according to a study published recently ...

Study finds that CPAP therapy reduces acid reflux in people with sleep apnea

October 3, 2016
A new study suggests that CPAP therapy may help improve the symptoms of nocturnal gastroesophageal reflux in patients with obstructive sleep apnea.

Financial obstacles only partly to blame for low CPAP acceptance

January 11, 2016
(HealthDay)—For patients with severe obstructive sleep apnea under a copayment health care system, obstacles other than finances are primarily responsible for reduced purchase of continuous positive airway pressure (CPAP) ...

Income level doesn't substantially impact CPAP use

October 30, 2015
(HealthDay)—Among patients with severe obstructive sleep apnea (OSA), patient neighborhood income level is not significantly associated with purchase of continuous positive airway pressure (CPAP) device, and the overall ...

Recommended for you

Sleep deficiency increases risk of a motor vehicle crash

April 4, 2018
Excessive sleepiness can cause cognitive impairments and put individuals at a higher risk of motor vehicle crash. However, the perception of impairment from excessive sleepiness quickly plateaus in individuals who are chronically ...

Sleep apnea study finds male-female differences in cerebral cortex thickness, symptoms

March 13, 2018
Researchers from the UCLA School of Nursing examined clinical records and magnetic resonance imaging brain scans of patients who were recently diagnosed with sleep apnea, and discovered several apparent connections between ...

Synthetic cannabinoid reduces sleep apnea

November 29, 2017
A synthetic version of a molecule found in the cannabis plant was safe and effective in treating obstructive sleep apnea in the first large, multi-site study of a drug for the sleep disorder funded by the National Institutes ...

Sleeping through the snoring: Researchers identify neurons that rouse the brain to breathe

November 2, 2017
A common and potentially serious sleep disorder, obstructive sleep apnea affects at least one quarter of U.S. adults and is linked to increased risk of diabetes, obesity and cardiovascular disease. In a paper published today ...

Remede system approved for sleep apnea

October 9, 2017
(HealthDay)—The Remede sleep system, an implanted device that treats central sleep apnea by activating a nerve that sends signals to the diaphragm to stimulate breathing, has been approved by the U.S. Food and Drug Administration.

Inflammation may precede sleep apnea, could be treatment target

September 1, 2017
Inflammation is traditionally thought of as a symptom of sleep apnea, but it might actually precede the disorder, potentially opening the door for new ways to treat and predict sleep apnea, according to researchers.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.